SOLIGENIX, INC. (SNGX) reporting calendar
SOLIGENIX, INC. files periodic reports with the SEC as SNGX on Nasdaq. Atlas tracks 73 filed reports for this issuer, each linked to its original EDGAR accession.
- Next window
- 13 Jul 2026 – 3 Sep 2026
- Latest report
- 10-Q
- Period ended
- 31 Mar 2026
- Filed
- 8 May 2026
- Reports on record
- 73
How this window is derived. Derived from this issuer's own filing history: 9 periods at a median 91-day cadence, filed a median 39 days after period end. The SEC does not publish forward reporting dates and Atlas does not estimate one.
Open SNGX market profile
Latest filing on SEC EDGAR ↗
Pharmaceutical Preparations reporting datesAll Nasdaq reporting dates
Filed periodic reports
| Form | Period ended | Filed | Lag | SEC accession |
|---|---|---|---|---|
| 10-Q | 31 Mar 2026 | 8 May 2026 | 38 days | 0001104659-26-057904 |
| 10-K | 31 Dec 2025 | 31 Mar 2026 | 90 days | 0001104659-26-037701 |
| 10-Q | 30 Sep 2025 | 7 Nov 2025 | 38 days | 0001104659-25-108475 |
| 10-Q | 30 Jun 2025 | 14 Aug 2025 | 45 days | 0001558370-25-011554 |
| 10-Q | 31 Mar 2025 | 9 May 2025 | 39 days | 0001558370-25-007171 |
| 10-K | 31 Dec 2024 | 21 Mar 2025 | 80 days | 0001558370-25-003459 |
| 10-Q | 30 Sep 2024 | 8 Nov 2024 | 39 days | 0001558370-24-015054 |
| 10-Q | 30 Jun 2024 | 9 Aug 2024 | 40 days | 0001558370-24-011740 |
| 10-Q | 31 Mar 2024 | 10 May 2024 | 40 days | 0001558370-24-007782 |
| 10-K | 31 Dec 2023 | 15 Mar 2024 | 75 days | 0001558370-24-003402 |
| 10-Q | 30 Sep 2023 | 13 Nov 2023 | 44 days | 0001558370-23-018818 |
| 10-Q | 30 Jun 2023 | 21 Aug 2023 | 52 days | 0001558370-23-015144 |
| 10-Q | 31 Mar 2023 | 15 May 2023 | 45 days | 0001558370-23-009929 |
| 10-K | 31 Dec 2022 | 31 Mar 2023 | 90 days | 0001558370-23-005304 |
| 10-Q | 30 Sep 2022 | 10 Nov 2022 | 41 days | 0001558370-22-017406 |
| 10-Q | 30 Jun 2022 | 12 Aug 2022 | 43 days | 0001558370-22-013491 |
| 10-Q | 31 Mar 2022 | 13 May 2022 | 43 days | 0001558370-22-008747 |
| 10-K | 31 Dec 2021 | 29 Mar 2022 | 88 days | 0001558370-22-004605 |
| 10-Q | 30 Sep 2021 | 12 Nov 2021 | 43 days | 0001558370-21-015775 |
| 10-Q | 30 Jun 2021 | 13 Aug 2021 | 44 days | 0001558370-21-011669 |
| 10-Q | 31 Mar 2021 | 18 May 2021 | 48 days | 0001213900-21-027232 |
| 10-K | 31 Dec 2020 | 30 Mar 2021 | 89 days | 0001213900-21-018698 |
| 10-Q | 30 Sep 2020 | 12 Nov 2020 | 43 days | 0001213900-20-036345 |
| 10-Q | 30 Jun 2020 | 14 Aug 2020 | 45 days | 0001213900-20-022284 |
| 10-Q | 31 Mar 2020 | 15 May 2020 | 45 days | 0001213900-20-012580 |
| 10-K | 31 Dec 2019 | 30 Mar 2020 | 90 days | 0001213900-20-007959 |
| 10-Q | 30 Sep 2019 | 12 Nov 2019 | 43 days | 0001213900-19-022914 |
| 10-Q | 30 Jun 2019 | 13 Aug 2019 | 44 days | 0001213900-19-015532 |
| 10-Q | 31 Mar 2019 | 14 May 2019 | 44 days | 0001213900-19-008583 |
| 10-K | 31 Dec 2018 | 26 Mar 2019 | 85 days | 0001213900-19-004865 |
| 10-Q | 30 Sep 2018 | 9 Nov 2018 | 40 days | 0001213900-18-015302 |
| 10-Q | 30 Jun 2018 | 8 Aug 2018 | 39 days | 0001213900-18-010449 |
| 10-Q | 31 Mar 2018 | 11 May 2018 | 41 days | 0001213900-18-005960 |
| 10-K | 31 Dec 2017 | 15 Mar 2018 | 74 days | 0001213900-18-003007 |
| 10-Q | 30 Sep 2017 | 6 Nov 2017 | 37 days | 0001213900-17-011390 |
| 10-Q | 30 Jun 2017 | 11 Aug 2017 | 42 days | 0001213900-17-008500 |
| 10-Q | 31 Mar 2017 | 11 May 2017 | 41 days | 0001213900-17-004946 |
| 10-K | 31 Dec 2016 | 27 Mar 2017 | 86 days | 0001213900-17-002845 |
| 10-Q | 30 Sep 2016 | 10 Nov 2016 | 41 days | 0001213900-16-018241 |
| 10-Q | 30 Jun 2016 | 11 Aug 2016 | 42 days | 0001213900-16-015752 |
Source: SEC EDGAR company submissions for CIK 0000812796. Atlas publishes filed facts only. The SEC does not publish forward reporting dates, so no announced future date is claimed here.